Clinical Trials Browser

Phase 2 × Carcinoma × Sorafenib × Clear all

Carcinoma, Carcinoma, Hepatocellular

NCT01556815 2012-04-25

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

Clinical Trials

Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma